Cargando…

Egg consumption and risk of non-alcoholic fatty liver disease

AIM: To evaluate the association between egg consumption and risk of non-alcoholic fatty liver disease (NAFLD) development. METHODS: This case-control study was conducted on individuals who were referred to two hepatology clinics in Tehran, Iran in 2015. The study included 169 patients with NAFLD an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mokhtari, Zeinab, Poustchi, Hossein, Eslamparast, Tannaz, Hekmatdoost, Azita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Case Control Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387362/ https://www.ncbi.nlm.nih.gov/pubmed/28443155 http://dx.doi.org/10.4254/wjh.v9.i10.503

Ejemplares similares

Probiotics and Nonalcoholic Fatty liver Disease
por: Eslamparast, Tannaz, et al.
Publicado: (2013)

Dietary Composition Independent of Weight Loss in the Management of Non-Alcoholic Fatty Liver Disease
por: Eslamparast, Tannaz, et al.
Publicado: (2017)

Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial
por: Saadati, Saeede, et al.
Publicado: (2019)

Short term effects of coffee components consumption on gut microbiota in patients with non-alcoholic fatty liver and diabetes: A pilot randomized placebo-controlled, clinical trial
por: Mansour, Asieh, et al.
Publicado: (2020)

Predictors for advanced fibrosis in morbidly obese non-alcoholic fatty liver patients
por: Zelber-Sagi, Shira, et al.
Publicado: (2017)

Dietary total antioxidant capacity is inversely associated with the odds of non-alcoholic fatty liver disease in people with type-2 diabetes
por: Salavatizadeh, Marieh, et al.
Publicado: (2022)

The association of dietary inflammatory index (DII) and central obesity with non-alcoholic fatty liver disease (NAFLD) in people with diabetes (T2DM)
por: Soltanieh, Samira, et al.
Publicado: (2023)

Nutrient patterns and non-alcoholic fatty liver disease in Iranian Adul: A case-control study
por: Salehi-sahlabadi, Ammar, et al.
Publicado: (2022)

Prevalence of hypothyroidism and effect of thyroid hormone replacement therapy in patients with non-alcoholic fatty liver disease: A population-based study
por: Almomani, Ashraf, et al.
Publicado: (2022)

Fatty liver is an independent risk factor for gallbladder polyps
por: Ahn, Dong-Won, et al.
Publicado: (2020)

Association of keratin 8/18 variants with non-alcoholic fatty liver disease and insulin resistance in Chinese patients: A case-control study
por: Li, Rui, et al.
Publicado: (2017)

Effects of supplementation with main coffee components including caffeine and/or chlorogenic acid on hepatic, metabolic, and inflammatory indices in patients with non-alcoholic fatty liver disease and type 2 diabetes: a randomized, double-blind, placebo-controlled, clinical trial
por: Mansour, Asieh, et al.
Publicado: (2021)

The Association between Nuts Intake and Non-Alcoholic Fatty Liver Disease (NAFLD) Risk: a Case-Control Study
por: Asbaghi, Omid, et al.
Publicado: (2020)

Association between dietary glycemic index and non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus
por: Salavatizadeh, Marieh, et al.
Publicado: (2023)

Red and Processed Meat Intake in Relation to Non-Alcoholic Fatty Liver Disease Risk: Results from a Case-Control Study
por: Rahimi-Sakak, Fatemeh, et al.
Publicado: (2022)

Dietary Total Antioxidant Capacity and Risk of Non-Alcoholic Fatty Liver Disease: A Case‐Control Study
por: Salehi-Sahlabadi, Ammar, et al.
Publicado: (2020)

Regional differences in genetic susceptibility to non-alcoholic liver disease in two distinct Indian ethnicities
por: Bale, Govardhan, et al.
Publicado: (2017)

Comparison of cardiometabolic risk factors between obese and non-obese patients with nonalcoholic fatty liver disease
por: Yari, Zahra, et al.
Publicado: (2023)

Artificial sweeteners are related to non-alcoholic fatty liver disease: Microbiota dysbiosis as a novel potential mechanism
por: Emamat, Hadi, et al.
Publicado: (2020)

Adherence to oxidative balance scores and lower odds of non-alcoholic fatty liver disease: a case–control study
por: Sohouli, Mohammad Hassan, et al.
Publicado: (2023)

Systematic review of zinc biochemical indicators and risk of coronary heart disease
por: Hashemian, Maryam, et al.
Publicado: (2015)

Calcium to magnesium intake ratio and non-alcoholic fatty liver disease development: a case-control study
por: Emamat, Hadi, et al.
Publicado: (2021)

Risk factors for hepatocellular carcinoma in cirrhosis due to nonalcoholic fatty liver disease: A multicenter, case-control study
por: Corey, Kathleen E, et al.
Publicado: (2017)

Assessment of Genetic Aspects of Non-alcoholic Fatty Liver and Premature Cardiovascular Events
por: Saki, Sara, et al.
Publicado: (2020)

The association between epicardial adipose tissue and non-alcoholic fatty liver disease: A systematic review of existing human studies
por: Emamat, Hadi, et al.
Publicado: (2021)

Comparing different non-invasive methods in assessment of the effects of curcumin on hepatic fibrosis in patients with non-alcoholic fatty liver disease
por: Saadati, Saeede, et al.
Publicado: (2018)

Dietary intake of fatty acids and risk of pancreatic cancer: Golestan cohort study
por: Ghamarzad Shishavan, Neda, et al.
Publicado: (2021)

The effects of onion consumption on treatment of metabolic, histologic, and inflammatory features of nonalcoholic fatty liver disease
por: Emamat, Hadi, et al.
Publicado: (2016)

Effects of Vitamin D Supplementation in Patients with Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Jalili, Mahsa, et al.
Publicado: (2019)

The Circulating CTRP13 in Type 2 Diabetes and Non-Alcoholic Fatty Liver Patients
por: Shanaki, Mehrnoosh, et al.
Publicado: (2016)

Prevalence of Non-Alcoholic Fatty Liver Disease and Its Predictors in North of Iran
por: AMIRKALALI, Bahareh, et al.
Publicado: (2014)

PNPLA3 and TM6SF2 polymorphisms in Brazilian patients with nonalcoholic fatty liver disease
por: Lisboa, Quelson Coelho, et al.
Publicado: (2020)

Validation of genetic variants associated with metabolic dysfunction-associated fatty liver disease in an ethnic Chinese population
por: Lee, Guan Huei, et al.
Publicado: (2020)

Leukocyte cell-derived chemotaxin-2 and fibroblast growth factor 21 in alcohol-induced liver cirrhosis
por: Sak, Jarosław Jerzy, et al.
Publicado: (2021)

Gut microbiota profile in patients with nonalcoholic fatty liver disease and presumed nonalcoholic steatohepatitis
por: Mohammadi, Zahra, et al.
Publicado: (2022)

Inverse relations between Helicobacter pylori infection and risk of esophageal precancerous lesions in drinkers and peanut consumption
por: Pan, Da, et al.
Publicado: (2022)

Alcohol intake is associated with a decreased risk of developing primary biliary cholangitis
por: French, Janine Adele, et al.
Publicado: (2022)

Factors related to hypermetabolism in individuals with type 2 diabetes mellitus and non-alcoholic fatty liver disease
por: Mansour, Asieh, et al.
Publicado: (2023)

Higher intakes of fiber, total vegetables, and fruits may attenuate the risk of all-cause and cause-specific mortality: findings from a large prospective cohort study
por: Ghorbani, Zeinab, et al.
Publicado: (2023)

The Prevalence of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus in an Iranian Population
por: Rabiee, Behnam, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nhu6i72j7efnqjt7caj0btp53c